.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Citi
Cantor Fitzgerald
Fish and Richardson
Express Scripts
Boehringer Ingelheim
Dow
Johnson and Johnson
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,125,939

« Back to Dashboard

Which drugs does patent 9,125,939 protect, and when does it expire?


Patent 9,125,939 protects ABILIFY and is included in two NDAs. There have been three Paragraph IV challenges on Abilify.

This patent has thirty-five patent family members in twenty-six countries.

Summary for Patent: 9,125,939

Title:Carbostyril derivatives and mood stabilizers for treating mood disorders
Abstract: The pharmaceutical composition of the present invention comprises a carbostyril derivative which is a dopamine-sero-tonin system stabilizer and a mood stabilizer in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof. The mood stabilizer may include but is not limited to lithium, valproic acid, divalproex sodium, carbamaza-pine, oxcarbamazapine, zonisamide, lamotragine, topiramate, gabapentin, levetiracetam or clonazepam. These compositions are used to treat patients with mood disorders, particularly bipolar disorder with or without psychotic features, mania or mixed episodes. Methods are provided for separate administration of a carbostyril derivative and a mood stabilizer to a patient with a mood disorder.
Inventor(s): Kikuchi; Tetsuro (Tokushima, JP), Iwamoto; Taro (Princeton, NJ), Hirose; Tsuyoshi (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:10/556,600
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
OtsukaABILIFYaripiprazoleTABLET, ORALLY DISINTEGRATING;ORAL021729-002Jun 7, 2006DISCNNoNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET, ORALLY DISINTEGRATING;ORAL021729-003Jun 7, 2006DISCNNoNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-006Nov 15, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-005Nov 15, 2002ABRXYesYes► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-001Nov 15, 2002ABRXYesYes► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-002Nov 15, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-003Nov 15, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-004Nov 15, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,125,939

PCT Information
PCT FiledMay 19, 2004PCT Application Number:PCT/US2004/013308
PCT Publication Date:December 09, 2004PCT Publication Number: WO2004/105682

International Patent Family for Patent: 9,125,939

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China102172401► Subscribe
China102172402► Subscribe
Colombia5630025► Subscribe
Cyprus1118313► Subscribe
Denmark1626721► Subscribe
EcuadorSP056182► Subscribe
European Patent Office1626721► Subscribe
European Patent Office2601953► Subscribe
Spain2609382► Subscribe
Georgia, Republic ofP20084567► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Cantor Fitzgerald
Fish and Richardson
US Army
Federal Trade Commission
Farmers Insurance
Johnson and Johnson
Healthtrust
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot